EMT is characterized by losing their epithelial cell identity marker E-cadherin and acquiring features of mesenchymal marker vimentin related to salient malignant properties of the tumor, including primary tumor formation, tumor stemness, malignant progression, tumor cell migration, intravasation to the blood, and metastasis (113, 114). The gene discussed is CDH1; the disease is neoplasm.